Bridging the Gap in Advanced Illness:
Pain Management, Ethics, and Communication
DATE & LOCATION: TBA
Nurses, Social Workers, & other Health Professionals: $120
Dr. Mary Lynn McPherson, Pharm. D., BCPS, CPE
Calling the Marines: Cutting Edge Pharmacotherapeutic Pain Management at the End
Patients with advanced illness often experience pain that is not optimally controlled with customary interventions. This presentation will provide participants with an overview of “red flags” that indicate therapeutic failure in pain management, situations requiring opioid rotation, opioidinduced neurotoxicity, methadone dosing, managing breakthrough pain
and the use of adjunctive analgesics such as ketamine and lidocaine. Using a case-based active learning teaching style, participants will leave this presentation with strategies they can implement immediately on return to their practice, which are best deployed through team-based care.
- Assess a patient with advanced illness for actual or potential pain, and identify at least three indicators of poorly controlled pain including opioid-induced neurotoxicity.
- Given an actual or simulated patient with poorly controlled pain, recommend dosing strategies for rotation to methadone, addition of ketamine or lidocaine.
- Given a case of a patient with advanced illness, recommend dosing strategies for the management of breakthrough pain including idiopathic pain, volitional pain and end-of-dose deterioration.
Dr. Russell Hilliard, PhD, LCSW, LCAT, MT-BC, CHRC
Provider Support and Distress: Ethical Dilemmas
The ethics of care requires a delicate balance between the conventional practice of medicine and the wishes of the patient. While planning a patient’s care not only should treatment options and likely outcomes be considered, but also patient values, hopes and beliefs. It is really dependent upon healthcare providers to inform patients and families of all treatment options to help them make an informed decision. Thiscourse discusses some of the ethical dilemmas that are faced by today’s healthcare provider while helping patients and families make an informed decision.
- Identify the 4 basic ethical principles.
- Identify when withholding or withdrawing treatment is ethically sound.
- Define “moral distress.”
- Articulate the 4 A’s approach in reducing and addressing moral distress.
- Recognize ways to resolve conflict within the plan of care.
- Identify ways to navigate conflict
Dr. Stephen A. Leedy, MD FAAHPM
Ice to Eskimos: Making the Case for Hospice Care to a Death Averse Society
If you think selling ice to Eskimos is hard, try selling hospice in 21st century America! Kubler-Ross described us as a “death-denying society” and Freud noted that “each of us, in the unconscious, is convinced of their immortality.” Strategies for successfully engaging such a death-averse populace in discussions about advanced illness and hospice care will be described. Specific tools targeting referring physicians will be demonstrated.
- Understand the challenges in making the case for hospice to a death-averse audience and identify strategies for overcoming these.
- Describe the value of a professional sales force in increasing access to hospice services.
- Detail several novel approaches to community and physician engagement.
|7:30 AM – 8 AM||Registration|
|8:00 AM – 8:15 AM||Welcome & Introductions|
|8:15 AM – 10:15 AM|| Calling the Marines: Cutting Edge|
Pharmacotherapeutic Pain Management
at the End
|10:15 AM – 10:30 AM||Break|
|10:30 AM – 12:30 AM||Provider Support and Distress: Ethical Dilemmas|
|12:30 AM – 1:30 AM||Lunch|
|1:30 AM – 3:30 AM||Ice to Eskimos: Making the Case for Hospice Care to a Death Averse Society|
|3:30 AM – 3:45 AM||Closing/Evaluations|
Continuing Education Credits (CEUs/Clock Hours/Contact Hours/CMEs) will be awarded to Physicians, Nurses, and Social Workers who attend the entire presentation and complete an evaluation of the Bridging the Gap in Advanced Illness program. The program is geared toward the health care community, is open to the public, and is appropriate for all practice levels (applications pending approval).